Astellas Receives European Commission Approval for
Roxadustat is the first orally administered hypoxia-inducible factor (HIF) prolyl hydroxylase (PH) inhibitor available for adult patients with anemia...
Source: globenewswire.com
Stay updated with breaking news from Anna Otten. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roxadustat is the first orally administered hypoxia-inducible factor (HIF) prolyl hydroxylase (PH) inhibitor available for adult patients with anemia...